A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine (Q33363561)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine
scientific article

    Statements

    A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine (English)
    1 November 2004
    1705-1711

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit